US gives nod to Pfizer Covid vaccine for children aged 5-11
By MYBRANDBOOK
The United States has authorized the Pfizer Covid vaccine for children aged five-to-11, paving the way for 28 million young Americans to soon get immunized. The decision came after a high-level medical panel advising the government this week endorsed the shots, ruling that the known benefits outweighed the risks of side-effects.
"As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today's authorization," said acting Food and Drug Administration Chief Janet Woodcock in a statement.
The vaccine rollout should begin in earnest after the Centers for Disease Control and Prevention convenes a panel on Tuesday to further discuss clinical recommendations. Pfizer and its partner BioNTech announced this week.
The US government had bought 50 million more doses as it works to protect children, including eventually those under five. In a clinical trial involving more than 2,000 participants was found to be more than 90 percent effective at preventing symptomatic disease. The vaccine's safety was also studied in more than 3,000 children, and no serious side effects have been detected in the ongoing study. In this age group, the vaccine is given as two shots three weeks apart, dosed at 10 micrograms -- a third what is given to older age groups. Severe Covid is rarer in children than adults, but far from non-existent.
According to the CDC, there have been 8,300 Covid hospitalizations of children aged five-to-11 since the start of the pandemic, and 146 deaths. There have also been more than 5,000 pediatric cases of multisystem inflammatory syndrome in children (MIS-C), a rare but highly serious post-viral complication, including 46 deaths. Health authorities will continue to monitor for potentially highly rare side-effects, such as myocarditis and pericarditis (heart inflammation and inflammation around the heart). The clinical trials were too small to detect these, but the hypothesis is they will be exceedingly rare, because the effect is thought linked to testosterone levels.
Legal Battle Over IT Act Intensifies Amid Musk’s India Plans
The outcome of the legal dispute between X Corp and the Indian government c...
Wipro inks 10-year deal with Phoenix Group's ReAssure UK worth
The agreement, executed through Wipro and its 100% subsidiary,...
Centre announces that DPDP Rules nearing Finalisation by April
The government seeks to refine the rules for robust data protection, ensuri...
Home Ministry cracks down on PoS agents in digital arrest scam
Digital arrest scams are a growing cybercrime where victims are coerced or ...
ICONS OF INDIA : SHAILENDER KUMAR
Shailender Kumar is senior vice president and regional managing direct...
ICONS OF INDIA : RAJESH NAMBIAR
Rajesh leads the company’s India associates and enhances relationshi...
Icons Of India : NATARAJAN CHANDRASEKARAN
Natarajan Chandrasekaran (Chandra) is the Chairman of Tata Sons, the h...
RailTel Corporation of India Limited
RailTel is a leading telecommunications infrastructure provider in Ind...
NSE - National Stock Exchange
NSE is the leading stock exchange in India....
IOCL - Indian Oil Corporation Ltd.
IOCL is India’s largest oil refining and marketing company ...
Indian Tech Talent Excelling The Tech World - NEAL MOHAN, CEO - Youtube
Neal Mohan, the CEO of YouTube, has a bold vision for the platform’s...
Indian Tech Talent Excelling The Tech World - Steve Sanghi, Executive Chair, Microchip
Steve Sanghi, the Executive Chair of Microchip Technology, has been a ...
Indian Tech Talent Excelling The Tech World - ANJALI SUD, CEO – Tubi
Anjali Sud, the former CEO of Vimeo, now leads Tubi, Fox Corporation...